Product
Osilodrostat
Name
Isturisa
INN Name
Osilodrostat
FDA Approved
Yes
2 clinical trials
1 organization
3 indications
1 document
Indication
Cushing's syndromeIndication
Cushing syndromeIndication
Adrenal InsufficiencyClinical trial
A Retrospective Observational Study to Evaluate the Safety and Effectiveness of Osilodrostat for the Treatment of Non-Cushing's Disease Cushing's Syndrome (LINC7)Status: Completed, Estimated PCD: 2023-09-30
Clinical trial
A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid ReplacementStatus: Recruiting, Estimated PCD: 2027-05-01
Document
DailyMed Label: IsturisaOrganization
Recordati Rare Diseases, Inc.